Myomo
MYOMyomo Inc. is a wearable medical robotics company that specializes in myoelectric-controlled upper limb orthoses for individuals with neuromuscular disorders and paralysis.
Earnings
Next report
Date not yet announcedCompetitors
By market cap
By revenue growth
Profile
Myomo Inc. is a wearable medical robotics company that specializes in myoelectric-controlled upper limb orthoses for individuals with neuromuscular disorders and paralysis. The company's core value proposition is providing a non-invasive solution that enables patients with conditions such as stroke, brachial plexus injury, and spinal cord injury to regain functional movement in their arms and hands. Myomo operates a direct-to-patient billing model and partners with clinical facilities to integrate its technology into the standard of care for rehabilitation.
Myomo is a first-mover in the myoelectric upper limb orthosis market, offering the only commercially available device in the U.S. that utilizes a patient's own muscle signals to restore movement to paralyzed limbs.
FAQ
- What is Myomo's market cap?
- Myomo (MYO) has a market capitalization of $51.9M and trades on AMEX.
- Who are Myomo's competitors?
- Myomo's key competitors include Lifeward, Hinge Health, Inc., Orthofix Medical Inc. Common Stock (DE), and others. These companies compete in similar markets and product categories.
- Who does Myomo partner with?
- Myomo's notable partners include Cogmedix, AB Corp, Cleveland Clinic, and others.
- Where is Myomo headquartered?
- Myomo is headquartered in United States of America and employs approximately 106 people. It has been publicly traded since 2017.